Clinical Trial Update: Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating embolization for liver metastases from malignant neuroendocrine tumors has completed enrollment; the study status is listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Neuroendocrine Tumor

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Neuroendocrine Tumor, Malignant, Liver Metastases | Phase 2 | Status: COMPLETED